EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteomic analysis identifies HMGA2 as a novel biomarker of overall survival in papillary renal cell carcinoma

Tian Wei, Huiya Xu, Huishan Liang, Yating Lian, Huiyu Chen, Zhangyi Zheng, Minghui Zhong, Junfeng Liu, Ran Wang, Fen Wang iD

Cancer Medicine · 2023-07 · 12 (13) · 14851-14864

DOI: 10.1002/cam4.6077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 07.06.2023. Verfasst von Tian Wei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, PR China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Although papillary renal cell carcinoma (PRCC) has a relatively favorable prognosis, a small number of patients with lymph node or distant metastasis have a poor prognosis. Owing to the complex typing and heterogeneity of PRCC, it remains difficult to provide risk stratification. The objective of our research was to identify potential markers of PRCC prognosis.

Methods

We performed proteomics and bioinformatics analyses on six pairs of formalin‐fixed paraffin‐embedded tumor and paired normal tissue samples. The Cancer Genome Atlas (TCGA) data were used to analyze the prognostic value of differentially expressed proteins (DEPs) in PRCC. We verified the expression of the major biomarker through immunohistochemistry (IHC) in 91 PRCC tumor specimens.

Results

Proteomic analysis revealed 1544 DEPs between tumor and paired normal tissues. PRCC transcriptomic data from the TCGA database revealed that compared to non‐tumor tissues, the expression of high‐mobility group protein A2 (HMGA2) was upregulated in tumor tissues, and patients with high HMGA2 expression exhibited shorter overall survival times. HMGA2 was associated with PRCC tissue subtype and higher cell pleomorphism. Both TCGA and IHC results showed that HMGA2 expression was associated with lymph node metastasis and clinical stage.

Conclusion

HMGA2 was positively correlated with malignant progression and could be a valuable novel prognostic biomarker for PRCC risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsHumansBiomarkers, TumorPrognosisProteomicsHMGA2 Protein

Stichwörter der Autor:innen

HMGA2TCGApapillary renal cell carcinomaprognosisproteomics

Substanzen

Biomarkers, TumorHMGA2 protein, humanHMGA2 Protein

Autor:innen und Institutionen

  • Department of Pathology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, PR China.
  • Department of Pathology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, PR China.
  • Department of Pathology, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, PR China.

ORCID-Profile: Fen Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wei, T., Xu, H., Liang, H., Lian, Y., Chen, H., Zheng, Z., Zhong, M., Liu, J., Wang, R., & Wang, F. (2023). Proteomic analysis identifies HMGA2 as a novel biomarker of overall survival in papillary renal cell carcinoma. Cancer Medicine, 12(13), 14851-14864. https://doi.org/10.1002/cam4.6077

Vancouver

Wei T, Xu H, Liang H, Lian Y, Chen H, Zheng Z, et al. Proteomic analysis identifies HMGA2 as a novel biomarker of overall survival in papillary renal cell carcinoma. Cancer Medicine. 2023;12(13):14851-14864. doi:10.1002/cam4.6077

BibTeX
@article{Wei2023,
  author = {Wei, Tian and Xu, Huiya and Liang, Huishan and Lian, Yating and Chen, Huiyu and Zheng, Zhangyi and Zhong, Minghui and Liu, Junfeng and Wang, Ran and Wang, Fen},
  title = {Proteomic analysis identifies HMGA2 as a novel biomarker of overall survival in papillary renal cell carcinoma},
  journal = {Cancer Medicine},
  year = {2023},
  volume = {12},
  number = {13},
  pages = {14851--14864},
  doi = {10.1002/cam4.6077}
}
Kostenlos starten →